Computational analysis of cancer genome sequencing data

Author(s):  
Isidro Cortés-Ciriano ◽  
Doga C. Gulhan ◽  
Jake June-Koo Lee ◽  
Giorgio E. M. Melloni ◽  
Peter J. Park
2014 ◽  
Vol 30 (17) ◽  
pp. 2498-2500 ◽  
Author(s):  
Weixin Wang ◽  
Panwen Wang ◽  
Feng Xu ◽  
Ruibang Luo ◽  
Maria Pik Wong ◽  
...  

2014 ◽  
Vol 31 (1) ◽  
pp. 116-118 ◽  
Author(s):  
Kenichi Chiba ◽  
Yuichi Shiraishi ◽  
Yasunobu Nagata ◽  
Kenichi Yoshida ◽  
Seiya Imoto ◽  
...  

10.1186/gm495 ◽  
2013 ◽  
Vol 5 (10) ◽  
pp. 91 ◽  
Author(s):  
Qingguo Wang ◽  
Peilin Jia ◽  
Fei Li ◽  
Haiquan Chen ◽  
Hongbin Ji ◽  
...  

2020 ◽  
Author(s):  
HoJoon Lee ◽  
Ahmed Shuaibi ◽  
John M. Bell ◽  
Dmitri S. Pavlichin ◽  
Hanlee P. Ji

ABSTRACTThe cancer genome sequencing has led to important discoveries such as identifying cancer gene. However, challenges remain in the analysis of cancer genome sequencing. One significant issue is that mutations identified by multiple variant callers are frequently discordant even when using the same genome sequencing data. For insertion and deletion mutations, oftentimes there is no agreement among different callers. Identifying somatic mutations involves read mapping and variant calling, a complicated process that uses many parameters and model tuning. To validate the identification of true mutations, we developed a method using k-mer sequences. First, we characterized the landscape of unique versus non-unique k-mers in the human genome. Second, we developed a software package, KmerVC, to validate the given somatic mutations from sequencing data. Our program validates the occurrence of a mutation based on statistically significant difference in frequency of k-mers with and without a mutation from matched normal and tumor sequences. Third, we tested our method on both simulated and cancer genome sequencing data. Counting k-mer involving mutations effectively validated true positive mutations including insertions and deletions across different individual samples in a reproducible manner. Thus, we demonstrated a straightforward approach for rapidly validating mutations from cancer genome sequencing data.


2015 ◽  
pp. btv430 ◽  
Author(s):  
Runjun D. Kumar ◽  
Adam C. Searleman ◽  
S. Joshua Swamidass ◽  
Obi L. Griffith ◽  
Ron Bose

Author(s):  
Xiaoyu He ◽  
Shanyu Chen ◽  
Ruilin Li ◽  
Xinyin Han ◽  
Zhipeng He ◽  
...  

Abstract Next-generation sequencing (NGS) technology has revolutionised human cancer research, particularly via detection of genomic variants with its ultra-high-throughput sequencing and increasing affordability. However, the inundation of rich cancer genomics data has resulted in significant challenges in its exploration and translation into biological insights. One of the difficulties in cancer genome sequencing is software selection. Currently, multiple tools are widely used to process NGS data in four stages: raw sequence data pre-processing and quality control (QC), sequence alignment, variant calling and annotation and visualisation. However, the differences between these NGS tools, including their installation, merits, drawbacks and application, have not been fully appreciated. Therefore, a systematic review of the functionality and performance of NGS tools is required to provide cancer researchers with guidance on software and strategy selection. Another challenge is the multidimensional QC of sequencing data because QC can not only report varied sequence data characteristics but also reveal deviations in diverse features and is essential for a meaningful and successful study. However, monitoring of QC metrics in specific steps including alignment and variant calling is neglected in certain pipelines such as the ‘Best Practices Workflows’ in GATK. In this review, we investigated the most widely used software for the fundamental analysis and QC of cancer genome sequencing data and provided instructions for selecting the most appropriate software and pipelines to ensure precise and efficient conclusions. We further discussed the prospects and new research directions for cancer genomics.


PLoS ONE ◽  
2013 ◽  
Vol 8 (6) ◽  
pp. e67980 ◽  
Author(s):  
Runjun D. Kumar ◽  
Li-Wei Chang ◽  
Matthew J. Ellis ◽  
Ron Bose

2013 ◽  
Vol 41 (7) ◽  
pp. e89-e89 ◽  
Author(s):  
Yuichi Shiraishi ◽  
Yusuke Sato ◽  
Kenichi Chiba ◽  
Yusuke Okuno ◽  
Yasunobu Nagata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document